In the newly released 'Paediatric drug optimization for respiratory syncytial virus (PADO-RSV) meeting report' by Global ...

Ziresovir earns global recognition, boosting hope for young RSV patients and strengthening ArkBio’s innovative pipeline.

GSK plc (GSK) said on Monday that its application for extending the use of its respiratory syncytial virus (RSV) vaccine ...

An outbreak of a highly contagious virus in China has health officials on alert. Cases of human metapneumovirus, or HMPV, which can lead to respiratory disease, are reportedly spiking in northern ...

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent threat to child health worldwide.

As China experiences a rise in respiratory infections this winter, one little-known virus has gotten a lot of attention – and some people may worry whether the rise in cases could be felt more ...

A new national guideline provides evidence-based recommendations for diagnosing, treating, and preventing pediatric respiratory syncytial virus (RSV) infections in China. Addressing 12 clinical ...

Countries such as China, India, Indonesia, Nigeria, and Pakistan account for majority of the global cases of RSV-associated acute lower respiratory infection.

The virus, first identified in 2001, is one of a handful of respiratory illnesses spreading this winter. This is what we know about the current outbreak. View on euronews ...

China's Zhifei will pay GSK about 2.3 billion pounds ($2.9 billion) for the exclusive rights to distribute GSK's shingles vaccine in China, the UK drugmaker said on Thursday, lower than previously ...

Cases are climbing in China, but the situation is very different from when COVID-19 emerged five years ago, medical experts say. HMPV is common and decades old.